+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Lipocalin-2/NGAL ELISA Kit Market - Global Forecast 2025-2030- Product Image
Human Lipocalin-2/NGAL ELISA Kit Market - Global Forecast 2025-2030- Product Image
Sale

Human Lipocalin-2/NGAL ELISA Kit Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6138645
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Human Lipocalin-2 ELISA kit market is advancing rapidly as evolving clinical and research requirements drive the adoption of innovative, highly sensitive assay technologies. Senior decision-makers across diagnostics, pharmaceuticals, and healthcare are leveraging Lipocalin-2, also known as Neutrophil Gelatinase-Associated Lipocalin (NGAL), for its actionable insights in high-priority disease areas.

Market Snapshot: Human Lipocalin-2 ELISA Kits

The market for Human Lipocalin-2 ELISA kits is fueled by increasing demand for precise biomarker quantification in cancer, cardiovascular, inflammatory, and kidney disease research. Innovations in microplate and point-of-care formats have expanded accessibility, while multiplexing platforms are reshaping diagnostic workflows. Geographic adoption varies with the Americas focusing on high-throughput applications, EMEA driving IVD validation, and Asia-Pacific accelerating manufacturing and deployment for broad segment reach. Technological enhancements and regulatory compliance are key growth accelerators as organizations seek versatile and reliable test solutions.

Scope & Segmentation

  • End User: Clinical laboratories, hospital laboratories, pharmaceutical companies, research centers
  • Application Area: Cancer biomarker detection, cardiovascular disease assessment, inflammatory disease studies (rheumatoid arthritis, sepsis), kidney disease diagnosis (acute kidney injury, chronic kidney disease)
  • Sample Type: Plasma, serum, urine
  • Kit Format: 96-well microplate, point-of-care device, strip well
  • Reaction Principle: Competitive ELISA, indirect ELISA, sandwich ELISA
  • Distribution Channel: Direct sales (field force, tender sales), distributors (local, national), e-commerce (manufacturer website, online marketplace)
  • Regional Coverage: Americas (United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina); Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Leading Companies: Thermo Fisher Scientific Inc., Merck KGaA, Bio-Techne Corporation, Abcam plc, Bio-Rad Laboratories, Inc., Enzo Biochem, Inc., RayBiotech, Inc., BioVendor - Laboratorni medicína a.s., Boster Biological Technology Co., Ltd., Sino Biological Inc.

Key Takeaways for Decision-Makers

  • The increasing adoption of multiplexed and miniaturized ELISA systems is streamlining both high-throughput research and point-of-care clinical workflows for Human Lipocalin-2 assessment.
  • Technological advances in sensitivity, including chemiluminescent and fluorescence readouts, enable early disease detection through finer biomarker fluctuation analysis.
  • Collaborative models in procurement and supply chain diversification are mitigating challenges caused by global tariffs and raw material costs.
  • Validated, IVD-compliant ELISA kits are gaining traction, with regulatory rigor especially evident across Western Europe and North America, reinforcing confidence in data integrity.
  • Regional manufacturing investments and public-private partnerships, particularly in Asia-Pacific and the Middle East, are supporting market expansion and technology transfer.
  • Strategic acquisition activity and consortium-based innovation among industry leaders are extending product portfolios and ensuring the relevance of emerging assay formats.

Tariff Impact: Strategic Considerations

Tariff adjustments in the United States have notably influenced the cost and sourcing dynamics for Human Lipocalin-2 ELISA kits. Increased duties on key raw materials, such as recombinant antibodies, are encouraging industry adaptation through alternative sourcing, localization, and domestic production expansions. These shifts are also prompting the formation of collaborative procurement models and regional supply chain strategies to stabilize pricing and maintain operational efficiency.

Human Lipocalin-2 ELISA Kit Market: Research Methodology

This report synthesizes insights from primary interviews with clinical and R&D leaders, combined with secondary analysis of scientific publications, regulatory filings, and industry reports. Competitive mapping was reinforced by reviewing company disclosures and patent databases. Segmentation and channel strategies were validated through data triangulation and stakeholder feedback sessions, ensuring robust and actionable insights.

Why This Report Matters

  • Delivers an integrated market-level view on key drivers, demand patterns, and evolving technology use in Lipocalin-2 and NGAL ELISA kit applications.
  • Equips executives with actionable analysis of supply chain resilience, tariff impacts, and regional adoption dynamics for informed decision-making.
  • Supports go-to-market planning with clear segmentation, competitor profiles, and distribution channel intelligence.

Conclusion

The Human Lipocalin-2 ELISA kit market is shaped by ongoing technological innovation, strategic supply chain management, and regional expansion. Senior stakeholders will benefit from comprehensive, data-driven guidance to capture emerging growth opportunities and enhance competitive advantage.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of multiplex NGAL ELISA platforms integrating biomarkers for comprehensive renal injury analysis
5.2. Development of ultra-sensitive chemiluminescent NGAL detection kits for early sepsis diagnosis
5.3. Expansion of automated high-throughput NGAL ELISA systems to support large-scale clinical trials
5.4. Rising investment in point-of-care NGAL testing devices for rapid acute kidney injury screening
5.5. Growth of research on NGAL levels as predictive biomarkers in chronic kidney disease progression
5.6. Partnerships between diagnostic developers and academic centers for novel NGAL assay validation
5.7. Impact of regulatory approvals on global market entry strategies for NGAL ELISA kits
5.8. Technological advancements in microfluidic NGAL immunoassays enhancing sensitivity and speed
5.9. Adoption of COVID-19 associated AKI monitoring protocols driving NGAL assay demand
5.10. Increasing competition from alternative biomarkers such as KIM-1 affecting NGAL kit positioning
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Human Lipocalin-2/NGAL ELISA Kit Market, by End User
8.1. Introduction
8.2. Clinical Laboratories
8.3. Hospital Laboratories
8.4. Pharmaceutical Companies
8.5. Research Centers
9. Human Lipocalin-2/NGAL ELISA Kit Market, by Application Area
9.1. Introduction
9.2. Cancer Biomarker Detection
9.3. Cardiovascular Disease Assessment
9.4. Inflammatory Disease Studies
9.4.1. Rheumatoid Arthritis
9.4.2. Sepsis
9.5. Kidney Disease Diagnosis
9.5.1. Acute Kidney Injury
9.5.2. Chronic Kidney Disease
10. Human Lipocalin-2/NGAL ELISA Kit Market, by Sample Type
10.1. Introduction
10.2. Plasma
10.3. Serum
10.4. Urine
11. Human Lipocalin-2/NGAL ELISA Kit Market, by Kit Format
11.1. Introduction
11.2. 96 Well Microplate
11.3. Point Of Care Device
11.4. Strip Well
12. Human Lipocalin-2/NGAL ELISA Kit Market, by Reaction Principle
12.1. Introduction
12.2. Competitive ELISA
12.3. Indirect ELISA
12.4. Sandwich ELISA
13. Human Lipocalin-2/NGAL ELISA Kit Market, by Distribution Channel
13.1. Introduction
13.2. Direct Sales
13.2.1. Field Force
13.2.2. Tender Sales
13.3. Distributors
13.3.1. Local Distributors
13.3.2. National Distributors
13.4. E Commerce
13.4.1. Manufacturer Website
13.4.2. Online Marketplace
14. Americas Human Lipocalin-2/NGAL ELISA Kit Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Human Lipocalin-2/NGAL ELISA Kit Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Human Lipocalin-2/NGAL ELISA Kit Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific Inc.
17.3.2. Merck KGaA
17.3.3. Bio-Techne Corporation
17.3.4. Abcam plc
17.3.5. Bio-Rad Laboratories, Inc.
17.3.6. Enzo Biochem, Inc.
17.3.7. RayBiotech, Inc.
17.3.8. BioVendor - Laboratorni medicína a.s.
17.3.9. Boster Biological Technology Co., Ltd.
17.3.10. Sino Biological Inc.
18. Research AI19. Research Statistics20. Research Contacts21. Research Articles22. Appendix
List of Figures
FIGURE 1. HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY APPLICATION AREA, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY APPLICATION AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REACTION PRINCIPLE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REACTION PRINCIPLE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET: RESEARCHAI
FIGURE 28. HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET: RESEARCHSTATISTICS
FIGURE 29. HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET: RESEARCHCONTACTS
FIGURE 30. HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY CANCER BIOMARKER DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY CANCER BIOMARKER DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY CARDIOVASCULAR DISEASE ASSESSMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY CARDIOVASCULAR DISEASE ASSESSMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY INFLAMMATORY DISEASE STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY INFLAMMATORY DISEASE STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SEPSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SEPSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY INFLAMMATORY DISEASE STUDIES, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY INFLAMMATORY DISEASE STUDIES, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIDNEY DISEASE DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIDNEY DISEASE DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY ACUTE KIDNEY INJURY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY ACUTE KIDNEY INJURY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIDNEY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIDNEY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY 96 WELL MICROPLATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY 96 WELL MICROPLATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY POINT OF CARE DEVICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY POINT OF CARE DEVICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY STRIP WELL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY STRIP WELL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REACTION PRINCIPLE, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REACTION PRINCIPLE, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY INDIRECT ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY INDIRECT ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY FIELD FORCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY FIELD FORCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY TENDER SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY TENDER SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY LOCAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY LOCAL DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY E COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY ONLINE MARKETPLACE, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY ONLINE MARKETPLACE, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY E COMMERCE, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY E COMMERCE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY INFLAMMATORY DISEASE STUDIES, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY INFLAMMATORY DISEASE STUDIES, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIDNEY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIDNEY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REACTION PRINCIPLE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REACTION PRINCIPLE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY E COMMERCE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY E COMMERCE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY INFLAMMATORY DISEASE STUDIES, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY INFLAMMATORY DISEASE STUDIES, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIDNEY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIDNEY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REACTION PRINCIPLE, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REACTION PRINCIPLE, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY E COMMERCE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY E COMMERCE, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 139. CANADA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. CANADA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. CANADA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 142. CANADA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 143. CANADA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY INFLAMMATORY DISEASE STUDIES, 2018-2024 (USD MILLION)
TABLE 144. CANADA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY INFLAMMATORY DISEASE STUDIES, 2025-2030 (USD MILLION)
TABLE 145. CANADA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIDNEY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 146. CANADA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIDNEY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 147. CANADA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 148. CANADA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 149. CANADA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2018-2024 (USD MILLION)
TABLE 150. CANADA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2025-2030 (USD MILLION)
TABLE 151. CANADA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REACTION PRINCIPLE, 2018-2024 (USD MILLION)
TABLE 152. CANADA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REACTION PRINCIPLE, 2025-2030 (USD MILLION)
TABLE 153. CANADA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. CANADA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. CANADA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 156. CANADA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 157. CANADA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 158. CANADA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 159. CANADA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY E COMMERCE, 2018-2024 (USD MILLION)
TABLE 160. CANADA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY E COMMERCE, 2025-2030 (USD MILLION)
TABLE 161. MEXICO HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. MEXICO HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. MEXICO HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 164. MEXICO HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 165. MEXICO HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY INFLAMMATORY DISEASE STUDIES, 2018-2024 (USD MILLION)
TABLE 166. MEXICO HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY INFLAMMATORY DISEASE STUDIES, 2025-2030 (USD MILLION)
TABLE 167. MEXICO HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIDNEY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 168. MEXICO HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIDNEY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 169. MEXICO HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 170. MEXICO HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 171. MEXICO HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2018-2024 (USD MILLION)
TABLE 172. MEXICO HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2025-2030 (USD MILLION)
TABLE 173. MEXICO HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REACTION PRINCIPLE, 2018-2024 (USD MILLION)
TABLE 174. MEXICO HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REACTION PRINCIPLE, 2025-2030 (USD MILLION)
TABLE 175. MEXICO HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. MEXICO HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. MEXICO HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 178. MEXICO HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 179. MEXICO HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 180. MEXICO HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 181. MEXICO HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY E COMMERCE, 2018-2024 (USD MILLION)
TABLE 182. MEXICO HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY E COMMERCE, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY INFLAMMATORY DISEASE STUDIES, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY INFLAMMATORY DISEASE STUDIES, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIDNEY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIDNEY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REACTION PRINCIPLE, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REACTION PRINCIPLE, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY E COMMERCE, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY E COMMERCE, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY INFLAMMATORY DISEASE STUDIES, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY INFLAMMATORY DISEASE STUDIES, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIDNEY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIDNEY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REACTION PRINCIPLE, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REACTION PRINCIPLE, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY E COMMERCE, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY E COMMERCE, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY INFLAMMATORY DISEASE STUDIES, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY INFLAMMATORY DISEASE STUDIES, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIDNEY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIDNEY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REACTION PRINCIPLE, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REACTION PRINCIPLE, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY E COMMERCE, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY E COMMERCE, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY INFLAMMATORY DISEASE STUDIES, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY INFLAMMATORY DISEASE STUDIES, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIDNEY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIDNEY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REACTION PRINCIPLE, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REACTION PRINCIPLE, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTORS, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTORS, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY E COMMERCE, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY E COMMERCE, 2025-2030 (USD MILLION)
TABLE 273. GERMANY HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. GERMANY HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. GERMANY HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY APPLICATION AREA, 2018-2024 (USD MILLION)
TABLE 276. GERMANY HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY APPLICATION AREA, 2025-2030 (USD MILLION)
TABLE 277. GERMANY HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY INFLAMMATORY DISEASE STUDIES, 2018-2024 (USD MILLION)
TABLE 278. GERMANY HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY INFLAMMATORY DISEASE STUDIES, 2025-2030 (USD MILLION)
TABLE 279. GERMANY HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIDNEY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 280. GERMANY HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIDNEY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 281. GERMANY HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 282. GERMANY HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 283. GERMANY HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2018-2024 (USD MILLION)
TABLE 284. GERMANY HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY KIT FORMAT, 2025-2030 (USD MILLION)
TABLE 285. GERMANY HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REACTION PRINCIPLE, 2018-2024 (USD MILLION)
TABLE 286. GERMANY HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY REACTION PRINCIPLE, 2025-2030 (USD MILLION)
TABLE 287. GERMANY HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. GERMANY HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. GERMANY HUMAN LIPOCALIN-2/NGAL ELISA KIT MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TAB

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Human Lipocalin-2/NGAL ELISA Kit Market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Bio-Techne Corporation
  • Abcam plc
  • Bio-Rad Laboratories, Inc.
  • Enzo Biochem, Inc.
  • RayBiotech, Inc.
  • BioVendor – Laboratorni medicína a.s.
  • Boster Biological Technology Co., Ltd.
  • Sino Biological Inc.

Related Topics

Related Reports

NGAL ELISA Kit Market - Global Forecast 2025-2030 - Product Image

NGAL ELISA Kit Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Human Gastrin ELISA Kit Market - Global Forecast 2025-2030 - Product Image

Human Gastrin ELISA Kit Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

25-Hydroxy Vitamin D (25-OH-VD) ELISA Kit Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Mouse TNF-a ELISA Kit Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Mouse TNF-a ELISA Kit Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Enzyme-linked Immunosorbent Assay (Elisa) Testing - Global Strategic Business Report - Product Image

Enzyme-linked Immunosorbent Assay (Elisa) Testing - Global Strategic Business Report

  • Report
  • 163 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.